Finance

Lists
ARDT:NYSE
Ardent Health Inc
$10.68
+1.23%
(+0.13) 1D
$10.68
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARDT...
Open
$10.63
High
$10.84
Low
$10.49
Mkt. cap
1.48B
Avg. vol.
411.81K
Volume
290.30K
P/E ratio
19.44
52-wk high
$15.48
52-wk low
$7.71
EPS
$0.55
Shares outstanding
141.05M
No. of employees
22K
Open
$10.63
High
$10.84
Low
$10.49
Mkt. cap
1.48B
Avg. vol.
411.81K
Volume
290.30K
P/E ratio
19.44
52-wk high
$15.48
52-wk low
$7.71
EPS
$0.55
Shares outstanding
141.05M
No. of employees
22K
News stories
From web sources and news partners
About Ardent Health Inc
CEO-
Employees22.4K
Founded2001
Headquarters-
SectorHealth care provider
Websiteardenthealth.com
Analyst ratings
Based on 9 analysts giving stock ratings to ARDT in the past 3 months
Buy
Buy
5
Hold
3
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ARDT in the last 3 months.
Highest
Current $10.68
$14.00 (+31.09%)
Average
$12.29 (+15.07%)
Lowest
$10.00 (-6.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/30/2026
Sean Dodge
BMO Capital
Hold
Initiated
$11.00
+3%
09/23/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
-
-
09/17/2026
Scott Fidel
Goldman Sachs
Hold
Maintained
$13.00
+21.7%
08/10/2026
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
$10.00
-6.4%
08/10/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$13.00
+21.7%
08/07/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
$12.00
+12.4%
08/06/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$13.00
+21.7%
08/06/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$14.00
+31.1%
08/05/2026
Jailendra Singh
Truist Financial
Buy
Reiterated
-
-
06/03/2026
A.J. Rice
UBS
Buy
Reiterated
$13.50
+26.4%
06/03/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
06/03/2026
Irene Nattel
RBC Capital
Buy
Maintained
$13.00
+21.7%
05/07/2026
Unknown Analyst
Stephens
Buy
Maintained
$14.00
+31.1%
03/06/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
$0.27 / $0.19
+43.95%beat
Revenue / Est. (USD)
1.62B / 1.59B
+2.05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.58B
1.61B
1.60B
1.62B
Cost of goods sold
676.96M
651.39M
661.43M
676.19M
Cost of revenue
676.96M
651.39M
661.43M
676.19M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
645.46M
653.77M
651.39M
674.11M
Operating expense
883.33M
848.94M
859.53M
890.29M
Total operating expenses
1.56B
1.50B
1.52B
1.57B
Operating income
16.46M
104.75M
80.91M
55.77M
Other non operating income
-
1.80M
5.89M
-
EBT including unusual items
-2.20M
92.37M
74.59M
43.20M
EBT excluding unusual items
2.54M
94.17M
74.59M
43.20M
Income tax expense
-3.41M
18.11M
16.10M
8.51M
Effective tax rate
154.79%
19.60%
21.59%
19.71%
Other operating expenses
198.71M
154.13M
165.15M
174.84M
Net income
-23.48M
44.96M
39.85M
16.90M
Net profit margin
-1.49%
2.80%
2.49%
1.04%
Earnings per share
0.83
0.36
0.30
0.27
Interest and investment income
-
-
-
-
Interest expense
-13.91M
-12.38M
-12.21M
-12.57M
Net interest expenses
-13.91M
-12.38M
-12.21M
-12.57M
Depreciation and amortization charges
39.16M
41.04M
42.99M
41.34M
EBITDA
55.61M
145.79M
123.90M
97.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps